Three-Dimensional Conformal Radiation Therapy and Intensity-Modulated Radiation Therapy Combined With Transcatheter Arterial Chemoembolization for Locally Advanced Hepatocellular Carcinoma: An Irradiation Dose Escalation Study

医学 肝细胞癌 毒性 放射治疗 急性毒性 经导管动脉化疗栓塞 队列 核医学 立体定向放射治疗 内科学 放射科 胃肠病学 肿瘤科 放射外科
作者
Zhi-Gang Ren,Jian-Dong Zhao,Ke Gu,Zhen Chen,Jun-Hua Lin,Zhi-Yong Xu,Wei-Gang Hu,Zhen-Hua Zhou,Lu-Ming Liu,Guo-Liang Jiang
出处
期刊:International Journal of Radiation Oncology Biology Physics [Elsevier BV]
卷期号:79 (2): 496-502 被引量:27
标识
DOI:10.1016/j.ijrobp.2009.10.070
摘要

Purpose To determine the maximum tolerated dose (MTD) of three-dimensional conformal radiation therapy (3DCRT)/intensity-modulated radiation therapy (IMRT) combined with transcatheter arterial chemoembolization for locally advanced hepatocellular carcinoma. Methods and Materials Patients were assigned to two subgroups based on tumor diameter: Group 1 had tumors <10 cm; Group II had tumors ≥10 cm. Escalation was achieved by increments of 4.0 Gy for each cohort in both groups. Dose-limiting toxicity (DLT) was defined as a grade of ≥3 acute liver or gastrointestinal toxicity or any grade 5 acute toxicity in other organs at risk or radiation-induced liver disease. The dose escalation would be terminated when ≥2 of 8 patients in a cohort experienced DLT. Results From April 2005 to May 2008, 40 patients were enrolled. In Group I, 11 patients had grade ≤2 acute treatment-related toxicities, and no patient experienced DLT; and in Group II, 10 patients had grade ≤2 acute toxicity, and 1 patient in the group receiving 52 Gy developed radiation-induced liver disease. MTD was 62 Gy for Group I and 52 Gy for Group II. In-field progression-free and local progression-free rates were 100% and 69% at 1 year, and 93% and 44% at 2 years, respectively. Distant metastasis rates were 6% at 1 year and 15% at 2 years. Overall survival rates for 1-year and 2-years were 72% and 62%, respectively. Conclusions The irradiation dose was safely escalated in hepatocellular carcinoma patients by using 3DCRT/IMRT with an active breathing coordinator. MTD was 62 Gy and 52 Gy for patients with tumor diameters of <10 cm and ≥10 cm, respectively. To determine the maximum tolerated dose (MTD) of three-dimensional conformal radiation therapy (3DCRT)/intensity-modulated radiation therapy (IMRT) combined with transcatheter arterial chemoembolization for locally advanced hepatocellular carcinoma. Patients were assigned to two subgroups based on tumor diameter: Group 1 had tumors <10 cm; Group II had tumors ≥10 cm. Escalation was achieved by increments of 4.0 Gy for each cohort in both groups. Dose-limiting toxicity (DLT) was defined as a grade of ≥3 acute liver or gastrointestinal toxicity or any grade 5 acute toxicity in other organs at risk or radiation-induced liver disease. The dose escalation would be terminated when ≥2 of 8 patients in a cohort experienced DLT. From April 2005 to May 2008, 40 patients were enrolled. In Group I, 11 patients had grade ≤2 acute treatment-related toxicities, and no patient experienced DLT; and in Group II, 10 patients had grade ≤2 acute toxicity, and 1 patient in the group receiving 52 Gy developed radiation-induced liver disease. MTD was 62 Gy for Group I and 52 Gy for Group II. In-field progression-free and local progression-free rates were 100% and 69% at 1 year, and 93% and 44% at 2 years, respectively. Distant metastasis rates were 6% at 1 year and 15% at 2 years. Overall survival rates for 1-year and 2-years were 72% and 62%, respectively. The irradiation dose was safely escalated in hepatocellular carcinoma patients by using 3DCRT/IMRT with an active breathing coordinator. MTD was 62 Gy and 52 Gy for patients with tumor diameters of <10 cm and ≥10 cm, respectively.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
尧九完成签到,获得积分10
1秒前
璃光浮月完成签到 ,获得积分10
1秒前
后陡门的夏完成签到,获得积分10
2秒前
罗大壮发布了新的文献求助10
2秒前
丁一完成签到,获得积分10
2秒前
li完成签到 ,获得积分10
3秒前
Sun完成签到,获得积分20
3秒前
3秒前
量子星尘发布了新的文献求助10
3秒前
4秒前
小七发布了新的文献求助10
4秒前
arabidopsis应助jiwn采纳,获得10
7秒前
ssz发布了新的文献求助10
7秒前
7秒前
LaTeXer应助外向含烟采纳,获得30
8秒前
爆米花应助尧九采纳,获得10
9秒前
大个应助烦的很有机会人采纳,获得10
9秒前
qq完成签到,获得积分10
10秒前
10秒前
10秒前
wenwen完成签到,获得积分10
11秒前
11秒前
11秒前
疯丫头发布了新的文献求助10
12秒前
12秒前
wanci应助身法马可波罗采纳,获得10
12秒前
13秒前
小敏哼完成签到,获得积分10
13秒前
13秒前
14秒前
caibuyaobing应助丘奇采纳,获得50
14秒前
李健应助张口结舌的果实采纳,获得10
15秒前
Cici发布了新的文献求助10
15秒前
芒果味的包子完成签到,获得积分10
15秒前
独特丹珍关注了科研通微信公众号
15秒前
喻箴发布了新的文献求助20
16秒前
苹果秋灵发布了新的文献求助10
16秒前
XHH1994发布了新的文献求助10
16秒前
化学小学生完成签到,获得积分10
16秒前
噔噔蹬完成签到 ,获得积分10
17秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3970048
求助须知:如何正确求助?哪些是违规求助? 3514739
关于积分的说明 11175783
捐赠科研通 3250115
什么是DOI,文献DOI怎么找? 1795198
邀请新用户注册赠送积分活动 875630
科研通“疑难数据库(出版商)”最低求助积分说明 804951